Evaluation of lipid-lowering therapy in patients with elevated lipoprotein(a) levels
Intensification of lipid-lowering medication within 30 days occurred in less than one-quarter of patients with elevated Lp(a). Future studies are needed to determine if aggressive LDL-C lowering is superior to Lp(a)-lowering to prevent ASCVD events in patients with elevated Lp(a).
Authors
- Mariam Fanous
- Pablo Ramírez (ORCID: https://orcid.org/0000-0003-0593-7161)
- Michael S. Kelly (ORCID: https://orcid.org/0000-0003-4272-8721)
- Dave L. Dixon (ORCID: https://orcid.org/0000-0001-7560-9521)
- Faryal Gohar
- Ruth N Jeminiwa
Institutions
- Thomas Jefferson University (US)
- Virginia Commonwealth University (US)
- Jefferson College (US)
Publication Details
- Journal
- Journal of clinical lipidology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1016/j.jacl.2025.04.200
- Citations
- 2
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 4.01